Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.51
Delayed Data
As of Jul 30
 +0.73 / +9.38%
Today’s Change
5.38
Today|||52-Week Range
15.40
+11.39%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close7.78
Today’s open7.77
Day’s range-- - --
Volume16,404
Average volume (3 months)27,041
Market cap$175.5M
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)-76.16%
Earnings growth (this year)-16.91%
Earnings growth (next 5 years)+26.83%
Revenue growth (last year)-27.51%
P/E ratio--
Price/Sales3.76
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
ASTAsterias Biotherapeu...-0.04-0.81%
PSTIPluristem Therapeuti...-0.04-1.66%
FATEFate Therapeutics In...-0.05-0.70%
CYTRCytRx Corp-0.10-3.50%
Data as of 07/30/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$47.1M
Annual profit (last year)$7.8M
Net profit margin16.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Vice President-
Operations
Yariv Gratz
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts